2:59 p.m.
Dear all,
The deadline for feedback on the EHDS electronic data guidelines is this Friday. Please
complete these short surveys before our Thursday call. We can then discuss feedback at our
regular call with the idea, that we as NFDI4Immuno may provide a collective feedback if
needed.
Here are the links again:
Biobank Data
- Health data from biobanks:
https://ec.europa.eu/eusurvey/runner/TEHDAS_Health_Cat6_2ndround
Genomic, Molecular and Pathogen Data
- Data on pathogens: https://ec.europa.eu/eusurvey/runner/TEHDAS_Health_Cat7_2ndround1
- Human genetic/genomic data:
https://ec.europa.eu/eusurvey/runner/TEHDAS_Health_Cat7_2ndround2
- Other human molecular data:
https://ec.europa.eu/eusurvey/runner/TEHDAS_Health_Cat7_2ndround3
Best,
Ulrik
Von: Stervbo,Ulrik
Gesendet: Dienstag, 18. Februar 2025 11:23
An: NFDI4Immuno All Members (nfdi4immuno-all(a)lists.nfdi.de)
<nfdi4immuno-all(a)lists.nfdi.de>
Betreff: WG: Ihr Feedback ist gefragt: TEHDAS work on EHDS Article 51 health categories
Dear Colleagues,
Please find below a list of surveys from TEHDAS2, who are developing common guidelines and
technical specifications for implementation of the European Health Data Space (EHDS).
Most relevant for us are probably the parts:
- Biobank Data
- health data from biobanks and associated databases:
https://ec.europa.eu/eusurvey/runner/TEHDAS_Health_Cat6_2ndround
- Genomic, Molecular and Pathogen Data
- Data on pathogens that impact human health:
https://ec.europa.eu/eusurvey/runner/TEHDAS_Health_Cat7_2ndround1
- Human genetic, epigenomic and genomic data:
https://ec.europa.eu/eusurvey/runner/TEHDAS_Health_Cat7_2ndround2
- Other human molecular data such as proteomic, transcriptomic, metabolomic, lipidomic
and other omic data: https://ec.europa.eu/eusurvey/runner/TEHDAS_Health_Cat7_2ndround3
The surveys close on February 28.
Best,
Ulrik
Von: healthdcat-ap <healthdcat-ap@bfarm.de<mailto:healthdcat-ap@bfarm.de>>
Gesendet: Montag, 17. Februar 2025 10:00
An: healthdcat-ap <healthdcat-ap@bfarm.de<mailto:healthdcat-ap@bfarm.de>>
Betreff: Ihr Feedback ist gefragt: TEHDAS work on EHDS Article 51 health categories
Sehr geehrte Damen und Herren,
wir möchten Sie darüber informieren, dass im Rahmen der TEHDAS-Workshopreihe zu den
Kategorien von Gesundheitsdaten gemäß Artikel 51 EHDS die Definitionen auf der Grundlage
Ihres Feedbacks aktualisiert wurden.
Sie sind nun herzlich eingeladen, an der zweiten Befragungsrunde teilzunehmen:
The Joint Action TEHDAS (second Joint Action Towards the European Health Data Space,
www.tehdas.eu<http://www.tehdas.eu>;) Work Package 5 organised working groups to
discuss the Minimum categories of electronic data for secondary use as listed in Article
51 of the EHDS
Regulation<https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CONSIL:PE_76_2024_INIT>.
This work is designed to provide input for EHDS-guidelines for health data holders,
focusing on clarification on the categories of health data in scope of the EHDS.
We have updated the full text definitions based on your input and would like you to review
and provide examples through the surveys we have developed. The surveys stay open until
February 28.
Date
Topic
Article 51 category
Survey link
November 19, 2024
Administrative Health Data
(c) aggregated data on healthcare needs, resources allocated to healthcare, the provision
of and access to healthcare, healthcare expenditure and financing
(e) healthcare-related administrative data, including dispensation, claims, and
reimbursement data
(j) data on professional status, and on the specialisation and institution of health
professionals involved in the treatment of a natural person
https://ec.europa.eu/eusurvey/runner/TEHDAS_Health_Cat1_2ndround
November 26, 2024
Registries & Research Data
(k) data from population-based health data registries such as public health registries
(l) data from medical registries and mortality registries
(p) data from research cohorts, questionnaires and surveys related to health, after the
first publication of the related results
https://ec.europa.eu/eusurvey/runner/TEHDAS_Health_Cat2_2ndround
November 29, 2024
Electronic Health Records & Clinical Data
(a) electronic health data from EHRs
(m) data from clinical trials, clinical studies, clinical investigations and performance
studies subject to Regulation (EU) No 536/2014, Regulation (EU) 2024/1938 of the European
Parliament and of the Council, Regulation (EU) 2017/745 and Regulation (EU) 2017/746
https://ec.europa.eu/eusurvey/runner/TEHDAS_Health_Cat3_2ndround
January 7, 2025
Socio-Economic, Environment and Behavioural Determinants
(b) data on factors impacting on health, including socio-economic, environmental and
behavioural determinants of health
https://ec.europa.eu/eusurvey/runner/TEHDAS_Health_Cat4_2ndround
January 10, 2025
Medicinal Products & Devices Registries
(h) personal electronic health data automatically generated through medical devices
(i) data from wellness applications
(n) other health data from medical devices
(o) data from registries for medicinal products and medical devices
https://ec.europa.eu/eusurvey/runner/TEHDAS_Health_Cat5_2ndround
January 14, 2025
Biobank Data
(q) health data from biobanks and associated databases.
https://ec.europa.eu/eusurvey/runner/TEHDAS_Health_Cat6_2ndround
January 17, 2025
Genomic, Molecular and Pathogen Data
(d) data on pathogens that impact human health
(f) human genetic, epigenomic and genomic data
(g) other human molecular data such as proteomic, transcriptomic, metabolomic, lipidomic
and other omic data
This survey is split for the different categories:
* d) Data on pathogens that impact human
health<https://ec.europa.eu/eusurvey/runner/TEHDAS_Health_Cat7_2ndround1>
* f) Human genetic, epigenomic and genomic
data<https://ec.europa.eu/eusurvey/runner/TEHDAS_Health_Cat7_2ndround2>
* g) Other human molecular data such as proteomic, transcriptomic, metabolomic,
lipidomic and other omic
data<https://ec.europa.eu/eusurvey/runner/TEHDAS_Health_Cat7_2ndround3>
Herzlichen Dank für Ihre Teilnahme!
Beste Grüße
Ihre
Datenzugangs- und Koordinierungsstelle
Abteilung 6, Innovationsmanagement, Geschäftsstellen
Bundesinstitut für Arzneimittel und Medizinprodukte
Kurt-Georg-Kiesinger-Allee 3
53175 Bonn
Telefon: +49 (0)228-99307-0
Internet: https://www.bfarm.de<https://www.bfarm.de/>
Wenn Sie möchten, können Sie jederzeit aus unserem Verteiler austreten. Dazu reicht eine
formlose E-Mail an healthdcat-ap@bfarm.de<mailto:healthdcat-ap@bfarm.de>
_______________________________________________________________
Mitten in der St. Elisabeth Gruppe:
St. Anna Hospital Herne, Marien Hospital Herne - Universitätsklinikum der Ruhr-Universität
Bochum,
Marien Hospital Witten, Rheumazentrum Ruhrgebiet, St. Marien Hospital Eickel,
Medizinische Reha für psychische Gesundheit, St. Elisabeth Stift Herne,
Senioreneinrichtungen Widumer Höfe,
Gästehaus St. Elisabeth, Ambulante Pflege, MVZ Ärzte - Herne | Wanne | Witten,
Lukas Hospiz Herne, St. Elisabeth Hospiz Witten, Bildungszentrum Ruhr, Bildungswerk,
Campus der St. Elisabeth Gruppe, Kinder in der St. Elisabeth Gruppe
_______________________________________________________________
Aufsichtsratsvorsitzender: Dr. Hans Willmes
Geschäftsführung: Dr. Sabine Edlinger, Simone Lauer
Registergericht:
HRB 9735 Amtsgericht Bochum
St.-Nr.: 325/5894/2251
_______________________________________________________________
Wir bitten wegen der aktuellen Virenangriffe um folgende Beachtung:
Das Sicherheitskonzept der St. Elisabeth Gruppe erlaubt momentan keine Zustellung von
.doc
(x) und .xls(x) Dateien! Schicken Sie Dokumente nur in Form von .pdf Dateien oder nehmen
Sie
Kontakt auf, um andere Übertragungsmöglichkeiten abzusprechen.